BUSINESS● LOW2h ago · Sep 29, 2026, 11:15 AM
AstraZeneca invests £1 . 5bn into US firm Summit for cancer drug tie - up
burytimes.co.uk · United Kingdom · global
AstraZeneca is investing £1.5 billion into Summit, a US firm, to collaborate on cancer drug development. This represents a major pharmaceutical partnership aimed at advancing cancer treatments.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
See it on the live mapUnited Kingdom and nearby eventsMore from United KingdomLatest stories and threat level
More from United Kingdom
POLITICS41m agoPablo Quirno, on the exploitation of resources in the Malvinas: "The United Kingdom is taking unilateral measures"ClarínMILITARY2h agoMystery in the United Kingdom after the release of suspects planning an attack on a military baseClarínPOLITICS2h agoThe united kingdom is acting with international partners to protect the two - state solution : united kingdom statement at the UN Security Councilglobalsecurity.org · SyriaPOLITICS2h agoWhat the united kingdom state pension triple lock is as it comes under scrutinyexpress.co.uk · United Kingdom
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS6m agoLiminatus Pharma regains Nasdaq complianceSeeking Alpha TechBUSINESS14m agoDon’t just watch history, let FirstBank help you own itPremium Times